* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download The gut microbiome analysis as source of (un)
Survey
Document related concepts
Genomic imprinting wikipedia , lookup
Genetically modified crops wikipedia , lookup
Genome evolution wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Ridge (biology) wikipedia , lookup
Genome (book) wikipedia , lookup
Microevolution wikipedia , lookup
Public health genomics wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
History of genetic engineering wikipedia , lookup
Biology and consumer behaviour wikipedia , lookup
Designer baby wikipedia , lookup
Minimal genome wikipedia , lookup
Gene expression profiling wikipedia , lookup
Transcript
Title: The gut microbiome analysis as source of (un)identified resistance genes & (non-)cultivable species Collaborators: Dr. John Penders, Molecular epidemiologist, Dr. Petra Wolffs, Medical Molecular Microbiologist, Prof. dr. Paul Savelkoul, Head of dept. medical microbiology, MUMC+ Maastricht, Proposal (250 words) Introduction: The gastrointestinal tract is an open system, which every day encounters a myriad of bacterial acquisitions originating from the environment (e.g. from food, water, soil, and other humans or animals). These incoming bacteria may harbor pathogenic bacteria; antibiotic resistance genes; virulence genes. In case of opportunistic pathogens of environmental or food-borne origin, such AMR/virulent bacteria can pose a direct threat to the host. Alternatively, these incoming microbes might transfer their resistance/virulence elements through horizontal gene transfer to the indigenous microbial communities. It remains largely unknown to which extent exposure to an endemic area, such as during travel to resourcelimited countries or admission to health-care facilities, poses a risk, as the presence of resistant/virulent bacteria in the human microbiota pose and effect on human/animal health or remain undetected unless they cause manifest infections. The human microbiota, in particular within the gastrointestinal tract, warrants special attention as perhaps the most accessible reservoir of (unkown) resistance genes in the bacterial community due to the high likelihood of contact and genetic exchange with potential pathogens. The majority of indigenous microbes cannot be cultivated, and it’s only since the recent application of sequencing/molecular profiling techniques that the human microbiota has been described in all complexity including the unculturable and rare taxa. Consequently, it is crucial to study the AMR (resistome) /virulence potential of the complete indigenous microbiota by applying molecular metagenomic approaches. By knowing the routes and arsenal of resistance genes in the gastrointestinal tract of humans and animals it can be anticipated on directly with treatment strategies and recognition of selection of specific genes. Hypothesis and Objectives: Antimicrobial resistance (AMR), one of the biggest global public health threats, jeopardizes effective prevention and treatment of an ever-increasing range of infections. Adequate surveillance of AMR is a prerequisite for informing global strategies, monitoring the effectiveness of interventions and detecting new trends and threats. So far, surveillance of AMR has been focused on clinical relevant pathogens or indicator organisms, thereby neglecting the full resistance potential in microbial ecosystems such as the gut microbiome of man and animal. Objectives: i. Microbiome analysis in man an animals ii. surveillance of acquisition of known and newly identified AMR genes from with particular focus on the human-animal- environment interface. high-risk environments iii. unraveling the extent to which risk factors contribute to dissemination of risk environments, and; AMR from high to low- iv. identifying targets to prevent AMR acquisition. Setting and Methods: Department of Medical Microbiology MUMC+. Techniques available: NGS sequencing pipelines, Reistome PCR analysis, Real time PCR, Bacterial microbiome profiling; multilayer resistome analysis. Requirements candidate: Molecular microbiologist; biooinformatician; epidemiologist Keywords: Microbiome, antibiotic resistance; resistome; NGS; profiling Selected publications: von Wintersdorff CJ, Wolffs PF, Savelkoul PHM, Nijsen RR, Lau S, Gerhold K, Hamelmann E, Penders J. The gut resistome is highly dynamic during the first months of life. Future Microbiol. 2016 Apr;11:501-10. doi: 10.2217/fmb.15.154. Epub 2016 Apr 11. Janssens PL, Penders J, Hursel R, Budding AE, Savelkoul PHM, Westerterp-Plantenga MS. Long-Term Green Tea Supplementation Does Not Change the Human Gut Microbiota. PLoS One. 2016 Apr 7;11(4):e0153134. doi: 10.1371/journal.pone.0153134. eCollection 2016. von Wintersdorff CJ, Penders J, van Niekerk JM, Mills ND, Majumder S, van Alphen LB, Savelkoul PHM, Wolffs PF. Dissemination of Antimicrobial Resistance in Microbial Ecosystems through. Horizontal Gene Transfer. Front Microbiol. 2016 Feb 19;7:173. doi: 10.3389/fmicb.2016.00173. eCollection 2016. Kluytmans-van den Bergh MF, Huizinga P, Bonten MJ, Bos M, De Bruyne K, Friedrich AW, Rossen JW, Savelkoul PHM, Kluytmans JA. Presence of mcr-1-positive Enterobacteriaceae in retail chicken meat but not in humans in the Netherlands since 2009. Euro Surveill. 2016 Mar 3;21(9). doi: 10.2807/15607917.ES.2016.21.9.30149. van Best N, Hornef MW, Savelkoul PHM, Penders J. On the origin of species: Factors shaping the establishment of infant’s gut microbiota. Birth Defects Res C Embryo Today. 2015 Dec;105(4):240-51. doi: 10.1002/bdrc.21113. Epub 2015 Nov 26 Mbakwa CA, Penders J, Savelkoul PHM, Thijs C, Dagnelie PC, Mommers M, Arts IC. Gut colonization with methanobrevibacter smithii is associated with childhood weight development. Obesity (Silver Spring). 2015 Dec;23(12):2508-16. doi: 10.1002/oby.21266. Epub 2015 Nov 2. Aguirre M, Eck A, Koenen ME, Savelkoul PHM, Budding AE, Venema K. Diet drives quick changes in the metabolic activity and composition of human gut microbiota in a validated in vitro gut model. Res Microbiol. 2016 Feb-Mar;167(2):114-25. doi: 10.1016/j.resmic.2015.09.006.Epub 2015 Oct 24. Tedjo DI, Jonkers DM, Savelkoul PHM, Masclee AA, van Best N, Pierik MJ, Penders J. The effect of sampling and storage on the fecal microbiota composition in healthy and diseased subjects. PLoS One. 2015 May 29;10(5):e0126685. doi: 10.1371/journal.pone.0126685.